×
Import Page Template
Please Wait a Moment
About
What We Stand For
CTS History
Board Of Directors
Senior Leadership
Services
Donor Testing
Plasma Testing
Research & Development
Resources
Accreditation/ Licenses
Assays
Helpful Information
News
Research Publications & Presentations
Articles
Communications
Videos
Contact Us
Lab Addresses
Client Services
Media Inquiries
General Contact
Careers
CTS Connect Login
|
X
About
What We Stand For
CTS History
Board Of Directors
Senior Leadership
Services
Donor Testing
Plasma Testing
Research & Development
Resources
Accreditation/ Licenses
Assays
Helpful Information
News
Research Publications & Presentations
Articles
Communications
Videos
Contact Us
Lab Addresses
Client Services
Media Inquiries
General Contact
Careers
CTS Connect Login
Publications & Presentations
News
Research Publications & Presentations
Research Publications & Presentations
Articles
Communications
Videos
Presentations
Implementation of Licensed Babesia Testing
FDA Reentry Guidance 2017
Packing and Shipping Samples
Sample Tube Labeling
17
Jul
CTS Representation at Major Global Scientific Forums This Summer
SuperUser Account
|
17 Jul, 2025
|
Research
,
SARS-CoV-2
,
IPFA/PEI
,
ISBT
,
Blood Donation
,
Plasma Donation
|
Creative Testing Solutions continues to prove its commitment to advancing transfusion safety through active participation in global scientific forums. This summer, our Vice President of Scientific Affairs Dr. Marion Lanteri represented CTS as both a presenter and participant at two major international conferences: the IPFA/PEI 31st International Workshop in Heidelberg, Germany, and the ISBT 2025 Congress in Milan, Italy.
Read More
04
Dec
Spike and nucleocapsid antibody dynamics following SARS-CoV-2 infection and vaccination
SuperUser Account
|
04 Dec, 2024
|
Research
,
Immunology (other than RBC serology)
,
Infectious disease testing
|
CTS supports ongoing research with a wide variety of healthcare partners to help safeguard the blood and plasma supply. In this publication, Scientific Affairs Vice President Marion Lanteri and Research and Development Technical Director Valerie Green contributed to the following publication regarding COVID-19 convalescent plasma.
Read More